Rangeley Capital’s iTeos Therapeutics ITOS Stock Holding History

Rangeley Capital’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-302,080	Closed	-$3.01M	–	134
2025 Q2	$3.01M	Buy	+302,080	New	+$2.43M	3.59%	11

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Rangeley Capital's ITOS Position: Q3 2025 in Review

Rangeley Capital sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 302,080 shares — an estimated $3.01M sold.

Rangeley Capital first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $3.01M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Rangeley Capital reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Rangeley Capital sold 302,080 iTeos Therapeutics shares in Q3 2025, an estimated $3.01M.
Rangeley Capital first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
Rangeley Capital's iTeos Therapeutics position peaked at $3.01M in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Rangeley Capital's 13F filing for Q3 2025, filed 14 Nov 2025.